三阴性乳腺癌
乳腺癌
下调和上调
癌症研究
小RNA
转录组
基因表达谱
生物
癌症
肿瘤科
内科学
基因表达
医学
基因
遗传学
作者
Dasom Son,Yesol Kim,Sera Lim,Hyeok-Gu Kang,Dahyun Kim,Jee Won Park,Jee Won Park,Woosung Cheong,Hyun Kyung Kong,Wonshik Han,Woong‐Yang Park,Kyung‐Hee Chun,Jong Hoon Park,Jong Hoon Park
出处
期刊:Cancer Letters
[Elsevier BV]
日期:2019-04-17
卷期号:454: 224-233
被引量:75
标识
DOI:10.1016/j.canlet.2019.04.006
摘要
Triple negative breast cancer (TNBC) has higher aggressiveness and poorer outcomes compared with other subtypes of breast cancer. However, the genomic and molecular aberrations of TNBC are largely unknown. In this study, miR-374a-5p was discovered as a novel TNBC-specific miRNA and its functions and the molecular mechanisms involved were investigated. Combined gene expression profiling of miRNA-microarray and human transcriptome dataset analysis revealed that miR-374a-5p is specifically upregulated in TNBC patients. Functional studies using in vitro and in vivo models indicated that upregulated miR-374a-5p promotes tumor progression in TNBC. miR-374a-5p was also found to directly target arrestin beta 1 (ARRB1) that is specifically downregulated in TNBC patients in several human genomic datasets. Overexpressed ARRB1 reduced TNBC cell growth and migration, and the ARRB1 expression level is inversely correlated with the histological grade of the breast cancer and positively associated with TNBC patient survival, suggestive of a tumor-suppressive function of ARRB1 in breast cancer. Interestingly, increased ARRB1 activates AMPK in TNBC cells, associated with the expression of miR-374a-5p. Taken together, the findings suggest that miR-374a-5p is a potential prognostic marker of TNBC.
科研通智能强力驱动
Strongly Powered by AbleSci AI